We are live on ! Find out more
RXST icon

RxSight
RXST

53 hedge funds and large institutions have $94.9M invested in RxSight in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 12 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 12

100% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 4

8% more funds holding

Funds holding: 49 → 53 (+4)

0.85% less ownership

Funds ownership: 33.83% → 32.97% (-0.85%)

14% less capital invested

Capital invested by funds: $110M → $94.9M (-$14.9M)

Holders
53
Holders Change
+4
Holders Change %
+8.16%
% of All Funds
0.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
25
Reduced
12
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$3.26M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.79M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$713K
4
PHP
Parkman Healthcare Partners
Connecticut
+$711K
5
BlackRock
BlackRock
New York
+$581K

Top Sellers

Rank Fund Capital Flow
1
EI
EAM Investors
California
-$2.48M
2
O
OrbiMed
New York
-$2.48M
3
RI
RTW Investments
New York
-$2.11M
4
BM
Bridger Management
New York
-$1.51M
5
EGI
EAM Global Investors
California
-$1.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$36.6M – – –
BlackRock
2
BlackRock
New York
$11.8M +$581K +42,326 +4%
Vanguard Group
3
Vanguard Group
Pennsylvania
$9.63M +$1.79M +130,694 +19%
Millennium Management
4
Millennium Management
New York
$5.83M -$326K -23,774 -5%
CAM
5
Cresset Asset Management
Illinois
$3.79M – – –
State Street
6
State Street
Massachusetts
$3.49M +$51.7K +3,765 +1%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$3.35M +$713K +51,885 +23%
Point72 Asset Management
8
Point72 Asset Management
Connecticut
$2.85M +$3.26M +237,641 New
BM
9
Bridger Management
New York
$2.66M -$1.51M -109,700 -33%
PHP
10
Parkman Healthcare Partners
Connecticut
$2M +$711K +51,761 +45%
Northern Trust
11
Northern Trust
Illinois
$1.8M +$17.7K +1,286 +0.9%
SC
12
Sessa Capital
New York
$1.63M -$391K -28,503 -17%
MF
13
Magnetar Financial
Illinois
$1.43M -$105K -7,652 -6%
N
14
Nuveen
North Carolina
$810K +$31K +2,254 +3%
BFS
15
Bradley Foster & Sargent
Connecticut
$688K +$17.4K +1,265 +2%
Russell Investments Group
16
Russell Investments Group
United Kingdom
$684K +$39.1K +2,844 +5%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$683K +$77.1K +5,614 +11%
Charles Schwab
18
Charles Schwab
California
$626K +$48.4K +3,522 +7%
IWM
19
IHT Wealth Management
Illinois
$507K +$16.3K +1,190 +3%
Bank of America
20
Bank of America
North Carolina
$416K -$28.5K -2,075 -6%
Morgan Stanley
21
Morgan Stanley
New York
$326K +$243K +17,708 +186%
RhumbLine Advisers
22
RhumbLine Advisers
Massachusetts
$304K +$23.2K +1,688 +7%
BFM
23
Boothbay Fund Management
New York
$299K +$20.5K +1,494 +6%
Citadel Advisors
24
Citadel Advisors
Florida
$287K -$83.7K -6,092 -20%
Boston Partners
25
Boston Partners
Massachusetts
$258K +$39.1K +2,844 +15%
1
2 3

RXST Hedge Fund Activity: Q3 2022 in Review

53 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q3 2022, worth a combined $94.9M — down 14% from $110M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new RXST positions and 4 closed out — a net gain of 4 holders — while 25 added to existing stakes and 12 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $3.26M. The largest seller was EAM Investors, exiting entirely with an estimated $2.48M sold.

  • 53 institutional investors held RxSight (RXST) as of Q3 2022, up from 49 in Q2 2022.
  • Funds reported $94.9M of RxSight stock for Q3 2022, down 14% quarter-over-quarter.
  • 8 funds opened new RxSight positions in Q3 2022 and 4 closed out, a net change of +4 holders.
  • The largest RxSight buyer in Q3 2022 was Point72 Asset Management, an estimated $3.26M added.
  • The largest RxSight seller in Q3 2022 was EAM Investors, an estimated $2.48M sold.

Based on aggregated 13F filings for Q3 2022.